![Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3975e299-51ba-482a-88eb-2c15b4ab7a01/fx1_lrg.jpg)
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology
![Clinical and Experimental Gastroenterology Citefactor.org-Journal|Research Paper|Indexing|Impact factor Clinical and Experimental Gastroenterology Citefactor.org-Journal|Research Paper|Indexing|Impact factor](https://www.citefactor.org/uploads/thumb/11787023.jpg)
Clinical and Experimental Gastroenterology Citefactor.org-Journal|Research Paper|Indexing|Impact factor
![Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines - Dieleman - 1998 - Clinical & Experimental Immunology - Wiley Online Library Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines - Dieleman - 1998 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ba5f6b0f-ce0b-4240-ad22-a90d33badc28/cei.v206.1.cover.jpg)